肿瘤患者LAK细胞体外实验性扩增及抗肿瘤研究

Experimental expansion and antitumor effects of LAK cells from cancer patient''s peripheral blood]

To augment the in vitro expansion of LAK cells, we added highly purified human recombinant interleukin-2, phytohemagglutinin and accessory cells (Uc cells) to the LAK culture system, with which huge number of LAK cells (LAK-L) were generated from originally small number of peripheral blood lymphocytes of cancer patients. These LAK-L cells exhibited similar antitumor activities in vitro and in vivo, as compared with LAK-S cells (LAK cells activated in short term culture). The phenotyping results suggested that there was more expression of IL-2 receptors in the LAK-L group than in the LAK-S group. The rapid proliferation of LAK-L cells was characterized by the expansion of OKT8 positive cells in the LAK-L populations.